Clinical Trials Browser

Phase 1/2 × INDUSTRY × pamrevlumab × Clear all

NCT02210559 2023-03-02

A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Phase 1/2 Completed

37 enrolled 16 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms